BioTelemetry is consistently trying to improve its cardiac monitoring and diagnostic services. The company also completed the acquisition of LifeWatch AG for about $280 million in July. With the buyout, BioTelemetry enhanced its position in the wireless medicine space, expanding its product portfolio and customer base in the cardiac monitoring and diagnostic services space.